Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer

1. Remon, J.
2. Besse, B.
3. Aix, S.P.
4. Callejo, A.
5. Al-Rabi, K.
6. Bernabe, R.
7. Greillier, L.
8. Majem, M.
9. Reguart, N.
10. Monnet, I.
11. Cousin, S.
12. Garrido, P.
13. Robinet, G.
14. Campelo, R.G.
15. Madroszyk, A.
16. Mazières, J.
17. Curcio, H.
18. Wasąg, B.
19. Pretzenbacher, Y.
20. Grillet, F.
21. Dingemans, A.-M.C.
22. Dziadziuszko, R.